Association between hemoglobin A1c variability and subclinical coronary atherosclerosis in subjects with type 2 diabetes - PubMed (original) (raw)
Association between hemoglobin A1c variability and subclinical coronary atherosclerosis in subjects with type 2 diabetes
Hae Kyung Yang et al. J Diabetes Complications. 2015 Aug.
Abstract
Aims: We examined the association between hemoglobin A1c (HbA1c) variability and subclinical coronary atherosclerosis in subjects with type 2 diabetes.
Methods: We used the multidetector coronary computed tomography data collected from subjects with type 2 diabetes who did not have a history of cardiovascular disease or angina symptoms. HbA1c measurements preceding the date of cardiac imaging were retrospectively collected, and intraindividual SD (HbA1c-SD), CV and adjusted SD of HbA1c measurements were calculated. Subclinical coronary atherosclerosis was defined as calcium score >400 without any cardiac symptoms.
Results: A total of 595 subjects were categorized according to the median value of each HbA1c variability indicators. The prevalence of subclinical coronary atherosclerosis was higher in higher HbA1c variability group compared with lower HbA1c variability group. Multivariable logistic regression analysis showed that higher HbA1c-SD and -CV were associated with the presence of subclinical coronary atherosclerosis, independent of mean HbA1c level in subjects with diabetes duration ≤10 years (OR [95% CI]; HbA1c-SD, 2.894 [1.105-7.584]; HbA1c-CV, 2.540 [1.022-6.316]).
Conclusions: Long-term stabilization of blood glucose level might be important in preventing subclinical coronary atherosclerosis in subjects with earlier period of type 2 diabetes.
Keywords: Coronary artery disease; Hemoglobin A1c; Hemoglobin A1c variability; Multidetector computed tomography; Type 2 diabetes mellitus.
Copyright © 2015 Elsevier Inc. All rights reserved.
Comment in
- Association of HbA1c variability with atherosclerosis in diabetes: simple marker, risk factor or statistical bias?
Monnier L, Colette C. Monnier L, et al. J Diabetes Complications. 2015 Aug;29(6):745-6. doi: 10.1016/j.jdiacomp.2015.05.002. Epub 2015 May 7. J Diabetes Complications. 2015. PMID: 26082425 No abstract available.
Similar articles
- Relationship Between Glycosylated Hemoglobin Variability and the Severity of Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus.
Liu X, Yang X, Wu N. Liu X, et al. J Diabetes Res. 2024 Aug 1;2024:9958586. doi: 10.1155/2024/9958586. eCollection 2024. J Diabetes Res. 2024. PMID: 39118831 Free PMC article. - HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes.
Hu J, Hsu H, Yuan X, Lou K, Hsue C, Miller JD, Lu J, Lee Y, Lou Q. Hu J, et al. J Endocrinol Invest. 2021 Jun;44(6):1229-1236. doi: 10.1007/s40618-020-01410-6. Epub 2020 Sep 8. J Endocrinol Invest. 2021. PMID: 32897535 - Impact of long-term glucose variability on coronary atherosclerosis progression in patients with type 2 diabetes: a 2.3 year follow-up study.
Li S, Tang X, Luo Y, Wu B, Huang Z, Li Z, Peng L, Ling Y, Zhu J, Zhong J, Liu J, Chen Y. Li S, et al. Cardiovasc Diabetol. 2020 Sep 25;19(1):146. doi: 10.1186/s12933-020-01126-0. Cardiovasc Diabetol. 2020. PMID: 32977802 Free PMC article. - Effects of Preoperative HbA1c Levels on the Postoperative Outcomes of Coronary Artery Disease Surgical Treatment in Patients with Diabetes Mellitus and Nondiabetic Patients: A Systematic Review and Meta-Analysis.
Wang J, Luo X, Jin X, Lv M, Li X, Dou J, Zeng J, An P, Chen Y, Chen K, Mu Y. Wang J, et al. J Diabetes Res. 2020 Feb 28;2020:3547491. doi: 10.1155/2020/3547491. eCollection 2020. J Diabetes Res. 2020. PMID: 32190696 Free PMC article. - The Scope of HbA1c Variability and Risk of Vascular Complications Among Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Prospective Studies.
Guo K, Zhao Q, Wang M, Lu Y, Wo M, Zhou X, Ying C. Guo K, et al. Horm Metab Res. 2022 Feb;54(2):94-103. doi: 10.1055/a-1730-4904. Epub 2022 Feb 7. Horm Metab Res. 2022. PMID: 35130570
Cited by
- Hemoglobin A1c Variability Predicts Symptoms of Depression in Elderly Individuals With Type 2 Diabetes.
Ravona-Springer R, Heymann A, Schmeidler J, Moshier E, Guerrero-Berroa E, Soleimani L, Sano M, Leroith D, Preiss R, Tzukran R, Silverman JM, Beeri MS. Ravona-Springer R, et al. Diabetes Care. 2017 Sep;40(9):1187-1193. doi: 10.2337/dc16-2754. Epub 2017 Jun 20. Diabetes Care. 2017. PMID: 28634202 Free PMC article. - Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study.
Lee YB, Han K, Kim B, Lee SE, Jun JE, Ahn J, Kim G, Jin SM, Kim JH. Lee YB, et al. Cardiovasc Diabetol. 2019 Nov 16;18(1):157. doi: 10.1186/s12933-019-0953-7. Cardiovasc Diabetol. 2019. PMID: 31733656 Free PMC article. - Association between coronary artery atherosclerosis and plasma glucose levels assessed by dual-source computed tomography.
Yu Y, Zhou Z, Sun K, Xi L, Zhang L, Yu L, Wang J, Zheng J, Ding M. Yu Y, et al. J Thorac Dis. 2018 Nov;10(11):6050-6059. doi: 10.21037/jtd.2018.10.62. J Thorac Dis. 2018. PMID: 30622776 Free PMC article. - Association between the Plasma-Glycosylated Hemoglobin A1c/High-Density Lipoprotein Cholesterol Ratio and Carotid Atherosclerosis: A Retrospective Study.
Hu X, Li W, Wang C, Zhang H, Lu H, Li G, Zhou Y, Dong H. Hu X, et al. J Diabetes Res. 2021 Nov 10;2021:9238566. doi: 10.1155/2021/9238566. eCollection 2021. J Diabetes Res. 2021. PMID: 34805413 Free PMC article. - Impact of long-term glycemic variability on development of atrial fibrillation in type 2 diabetic patients.
Gu J, Fan YQ, Zhang JF, Wang CQ. Gu J, et al. Anatol J Cardiol. 2017 Dec;18(6):410-416. doi: 10.14744/AnatolJCardiol.2017.7938. Anatol J Cardiol. 2017. PMID: 29256876 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical